9 December 20216 December 2021 DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) Company has a deep pipeline of predictable, scalable, cost-competitive products, addressing sustainability challenges across a wide range of industries
8 December 20157 December 2015 Commercializing Synthetic Biology Innovation to Tackle Climate Change and Feed a Growing Population
7 September 20154 September 2015 Schnelle Zulassung für Gentech-Kartoffel Einführung neuer Technologien durch die Hintertür?
